Identification of genes that may play critical roles in phenobarbital (PB)-induced liver tumorigenesis due to altered DNA methylation

Toxicological Sciences

Volumn 104, Issue 1, 2008, Pages 86-99

  Phillips, Jennifer M ^a   Goodman, Jay I ^b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

DNA methylation; Epigenetic; Mouse liver; Phenobarbital, tumors

Indexed keywords

CHYMASE; DNA; EPHRIN B2; GUANINE NUCLEOTIDE; PHENOBARBITAL; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER STAGING; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DNA ISOLATION; DNA METHYLATION; GENE IDENTIFICATION; LIVER CANCER; LIVER CARCINOGENESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANIMALS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PHENOBARBITAL;

MUS; RODENTIA;

EID: 45549092837     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn063     Document Type: Article

References (63)

1. Aydinlik, H., Nguyen, T. D., Moennikes, O., Bachmann, A., and Schwarz, M. (2001). Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 22, 7812-7816.
2. Bachman, A. N., Kamendulis, L. M., and Goodman, J. I. (2006a). Diethanolamine and phenobarbital produce an altered pattern of methylation in GC-rich regions of DNA in B6C3F1 mouse hepatocytes similar to that resulting from choline deficiency. Toxicol. Sci. 90, 317-320.
3. Bachman, A. N., Phillips, J. M. and Goodman, J. I. (2006b). Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice. Toxicol. Sci. 91, 393-405.
4. Becker, F. F. (1982). Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res. 42, 3918-3923.
5. Bhattacharya, S. K., Ramchandani, S., Cervoni, N., and Szyf, M. (1999). A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397, 579-583.
6. Cawley, S., Bekiranov, S., Ng, H. H., Kapranov, P., Sekinger, E. A., Kampa, D., Piccolboni, A., Sementchenko, V., Cheng, J., Williams, A. J., et al. (2004). Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499-509.
7. Counts, J. L., and Goodman, J. I. (1995). Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83, 13-15.
8. Counts, J. L., McClain, R. M., and Goodman, J. I. (1997). Comparison of effect of tumor promoter treatments on DNA methylation status and gene expression in B6C3F1 and C57BL/6 mouse liver and in B6C3F1 mouse liver tumors. Mol. Carcinog. 18, 97-106.
9. Counts, J. L., Sarmiento, J. I., Harbison, M. L., Downing, J. C., McClain, R. M., and Goodman, J. I. (1996). Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration. Carcinogenesis 17, 1251-1257.
10. Esteller, M. (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-298.
11. Fedorova, L., and Fedorov, A. (2003). Introns in gene evolution. Genetica 118, 123-131.
12. Feinberg, A. P., Ohlsson, R., and Henikoff, S. (2006). The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33.
13. Gale, N. W., Holland, S. J., Valenzuela, D. M., Flenniken, A., Pan, L., Ryan, T. E., Henkemeyer, M., Strebhardt, K., Hirai, H., Wilkinson, D. G., Pawson, T., Davis, S., and Yancopoulos, G. D. (1996). Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17 9-19.
14. Gonzalgo, M. L., Liang, G., Spruck, C. H., III., Zingg, J. M., Rideout, W. M., III., and Jones, P. A. (1997). Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57 594-599.
15. González-García, A., Pritchard, C. A., Paterson, H. F., Mavria, G., Stamp, G., and Marshall, C. J. (2005). RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7, 219-226.
16. Goodman, J. I, and Watson, R. E. (2002). Altered DNA methylation: A secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol 42, 501-525.
17. Hanahan, D., and Weinberg, G. F. (2000). The hallmarks of cancer. Cell 100, 57-70.
18. Hoberg, J. E., Yeung, F., and Mayo, M. W. (2004). SMRT derepression by the IkappaB kinase alpha: A prerequisite to NF-kappaB transcription and survival. Mol. Cell 16, 245-255.
19. Hu, M. C., Tang-Oxley, Q., Qiu, W. R., Wang, Y. P., Mihindukulasuriya, K. A., Afshar, R., and Tan, T. H. (1998). Protein phosphatase X interacts with c-Rel and stimulates c-Rel/nuclear factor kappaB activity. J. Biol. Chem. 50, 33561-33565.
20. Karashima, T., Sweeney, P., Kamat, A., Huang, S., Kim, S. J., Bar-Eli, M., McConkey, D. J., and Dinney, C. P. (2003). Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin. Cancer Res. 9, 2786-2797.
21. Katada, J., Muramatsu, M., Hayashi, I, Tsutsumi, M., Konishi, Y., and Majima, M. (2002). Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-anglotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J. Pharmacol. Exp. Ther. 302, 949-956.
22. Kolaja, K. L., Stevenson, D. E., Johnson, J. T., Walborg, E. F., Jr., and Klavnig, J. E. (1996a). Subshronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam. Appl. Toxsci. 29, 219-228.
23. Kolaja, K. L., Stevenson, D. E., Walborg, E. F., Jr., and Klaunig, J. E. (1996b). Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: Effects on DNA synthesis and apoptosis. Carcinogenesis 17, 947-954.
24. Lawrence, T., Hageman, T., and Balkwill, F. (2007). Sex, cytokines, and cancer. Science 317, 51-52.
25. Lee, S. K., Kim, J. H., Lee, Y. C., Cheong, J., and Lee, J. W. (2000). Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J. Biol. Chem. 275, 12470-12474.
26. Lévy, L., Neuveut, C., Renard, C. A., Charneau, P., Branchereau, S., Gauthier, F., Van Nhieu, J. T., Cherqui, D., Petit-Bertron, A. F., Mathieu, D., et al. (2002). Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. J. Biol. Chem. 277, 42386-42393.
27. Maekawa, H., Oike, Y., Kanda, S., Ito, Y., Yamada, Y., Kurihara, H., Nagai, R., and Suda, T. (2003). Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature. Arterioscler. Thromb. Vasc. Biol. 23, 2008-2014.
28. Masood, R., Xia, G., Smith, D. L., Scalia, P., Still, J. G., Tulpule, A., and Gill, P. S. (2005). Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: Phenotype switch from venous to arterial endothelium. Blood 105, 1310-1318.
29. Moennikes, O., Buchmann, A., Romualdi, A., Ott, T., Werringloer, J., Willecke, K., and Schwarz, M. (2000). Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res. 15, 5087-5091.
30. Morgan, H. D., Dean, W., Coker, H. A., Reik, W., and Petersen-Mahrt, S. K. (2004). Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J. Biol. Chem. 279 52351-52360.
31. Nakada, M., Niska, J. A., Miyamori, H., McDonough, W. S., Wu, J., Sato, H., and Berens, M. E. (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res. 64, 3179-3185.
32. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., and Karin, M. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124.
33. Naveh-Many, T., and Cedar, H. (1981). Active gene sequences are under-methylated. Proc. Natl. Acad. Sci, U.S.A. 78, 4246-4250.
34. Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science 194, 24-28.
35. Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448 313-317.
36. Phillips, J. M., Yamamoto, Y., Negishi, M., Maronpot, R. R., and Goodman, J. I. (2007). Orphan nuclear receptor constitutive active/ androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis. Toxicol. Sci. 96, 72-82.
37. Ramsahoye, B. H., Biniszkiewicz, D., Lyko, F., Clark, V., Bird, A. P., and Jaenisch, R. (2000). Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Cell Biol. 97, 5237-5242.
38. Rangarajan, A., and Weinberg, R. A. (2003). Comparative biology of mouse versus human cells: Modeling human cancer in mice. Nat. Rev. Cancer 3, 952-959.
39. Ray, J. S., Harbison, M. L., McClain, R. M., and Goodman, J. I. (1994). Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse live tumors. Mol. Carcinog. 9, 155-166.
40. Reik, W. (2007). Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425-432.
41. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
42. Sandelin, A., Carninci, P., Lenhard, B., Ponjavic, J., Hayashizaki, Y., and Hume, D. A. (2007). Mammalian RNA polymerase II core promoters: Insights from genome-wide studies. Nat. Rev. Genet. 9, 424-436.
43. Senga, T., Iwamoto, T., Kitamura, T., Miyake, Y., and Hamaguchi, M. (2001). JAK/STAT3-dependent activation of the Ra1GDS/Ral pathway in M1 mouse myeloid leukemia cells. J. Biol. Chem. 35, 32678-32681.
44. Shiraishi, M., Lerman, L. S., and Sekiya, T. (1995). Preferential isolation of DNA fragments associated with CpG islands. Proc. Natl. Acad. Sci. U.S.A. 92, 4229-4233.
45. Song, L., Zlobin, A., Ghoshal, P., Zhang, Q., Houde, C., Weijzen, S., Jiang, Q., Nacheva, E., Yagan, D., Davis, E., et al. (2005). Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. Cancer Res. 65, 4554-4561.
46. Steer, C. J. (1995). Liver regeneration. FASEB J. 9, 1396-1400.
47. Strathmann, J., Schwarz, M., Tharappel, J. C., Glauert, H. P., Spear, B. T., Robertson, L. W., Appel, K. E., and Bachmann, A. (2006). PCB; 153, a non-dioxin-like tumor promoter, selects for beta-catenin (Catnb)-mutated mouse liver tumors. Toxicol. Sci. 93, 34-40.
48. Sugatani, J., Kojima, H., Ueda, A., Kakizaki S., Yoshinari, K., Gong, Q. H., Owens, I. S., Negishi, M., and Sueyoshi, T. (2001). The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33, 1232-1238.
49. Terakawa, M., Tomimori, Y., Goto, M., and Fukuda, Y. (2006). Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils. Eur. J. Pharmacol. 538, 175-181.
50. Thiery, J. P. (2002). Epithetial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
51. Trosko, J. E., and Chang, C. C. (2001). Role of stem cells and gap junctional intercellular communication in human carcinogenesis. Radiat. Res. 155, 175-180.
52. Ulrey, C. L., Liu, L., Andrews, L. G., and Tollefsbol, T. O. (2005). The impact of metabolism on DNA methylation. Hum. Mol. Genet. 14 R139-R147.
53. van der Horst, E. H., Degenhardt, Y. Y., Strelow, A., Slavin, A., Chinn, L., Orf, J., Rong, M., Li, S., See, L. H., Nguyen, K. Q., et al. (2005). Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc. Natl. Acad. Sci. U.S.A. 102, 15901-15906.
54. Vorce, R. L., and Goodman, J. I. (1991). Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. Toxicol. Environ. Health 34, 367-384.
55. Ward, Y., Wang, W., Woodhouse, E., Linnoila, I, Liotta, L., and Kelly, K. (2001). Signal pathways which promote invasion and metastasis: Critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell. Biol. 21, 5958-5969.
56. Watson, R. E., and Goodman, J. I. (2002). Effects of phenobarbital on DNA methylation in GC-rich regions of hepatic DNA from mice that exhibit differential levels of susceptibility to liver tumorigenesis. Toxicol. Sci. 68, 51-58.
57. Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D. D. (2000). The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407, 920-923.
58. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., and Jaenisch, R. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324.
59. Whysner, J., Ross, P. M., and Williams, G. M. (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71, 53-91.
60. Wiseman, R. W., Stowers, S. J., Miller, E. C., Anderson, M. W., and Miller, J. A. (1986). Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc. Natl. Acad. Sci. U.S.A. 83, 5925-5829.
61. Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., and Maronpot, R. R. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64, 7197-7200.
62. Yoshizuka, N., Moriuchi, R., Mori, T., Yamada, K., Hasegawa, S., Maeda, T., Shimada, T., Yamada, Y., Kamihira, S., Tomonaga, M., et aL (2004). An alternative transcript derived from the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential. J. Biol. Chem. 279, 43998-44004.
63. Zhang, X., Gaspard, J. P., and Chung, D. C. (2001). Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 15, 6050-6054.